Want to join the conversation?
In 2H16, $ALXN will have multiple R&D milestones, including an update on progress with regulators for eculizumab in refractory MG, data from the Phase 3 trial of eculizumab in DGF, completion of enrollment in the Phase 3 NMO trial and ALXN1210 data in patients with PNH. $ALXN expects to deliver up to 6 product or indication approvals through 2018.
$GOOG’s Waymo accuses Uber of stealing its intellectual property. Startup Otto, which was recently acquired by Uber, also named in the lawsuit. Stage set for another dramatic legal battle!
We all knew $VALE CEO Murilo Ferreira was going out soon, but now I hear he has no idea who will succeed him!
$JCP, another traditional retailer that just shocked us with its biggest number of store closures.